Indometacin or indomethacin

This classification denotes an indole compound and cyclooxygenase inhibitor with the molecular formula C19H16ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XXE1CET956, chemically known as 1h-indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (9ci) but generally known as indometacin, which bears US NIH Compound Identifier 3715. European Medicines Agency schedules Indometacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08180MIG. The term INDOMETACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules indometacin in its Anatomical Therapeutic Chemical (ATC) Classification. INDOMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Indometacin or indomethacin bears US NLM identifiers UMLS ID C0021246 and NCI Concept Code C576.